News & Events

News

All categories

Earnings

Press Release

All years

2021

2020

2019

2018

2017

2016

2015

2014

Affimed to Present Clinical and Preclinical Data on Immune Cell Engagers at ASH

November 2, 2017

Affimed Announces Third Quarter 2017 Financial Results and Corporate Update Conference Call

October 30, 2017

Affimed to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology

September 22, 2017

Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer

September 13, 2017

Affimed to Present at the 2017 Wells Fargo Healthcare Conference – Boston

September 4, 2017

Affimed Reports Financial Results for Second Quarter 2017

August 1, 2017

Affimed Announces Second Quarter 2017 Financial Results and Corporate Update Conference Call

July 25, 2017

Affimed Presents Preclinical Data on AFM24 and AFM26 at EACR-AACR-SIC 2017

June 27, 2017

Affimed Presents Data on First-in-Class BCMA-Targeting Immune Cell Engager AFM26 at ASCO Annual Meeting 2017

June 6, 2017

Affimed to Present at the Jefferies 2017 Global Healthcare Conference – New York

May 30, 2017

Events

All

Scientific

Investors

04Jun

ASCO Annual Meeting

June 4 - 9, 2021 (virtual)

Webcasts
More events